IT1276555B1 - Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni - Google Patents

Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni

Info

Publication number
IT1276555B1
IT1276555B1 IT95RM000273A ITRM950273A IT1276555B1 IT 1276555 B1 IT1276555 B1 IT 1276555B1 IT 95RM000273 A IT95RM000273 A IT 95RM000273A IT RM950273 A ITRM950273 A IT RM950273A IT 1276555 B1 IT1276555 B1 IT 1276555B1
Authority
IT
Italy
Prior art keywords
pct
interluchina
bond
compositions
human
Prior art date
Application number
IT95RM000273A
Other languages
English (en)
Inventor
Gennaro Ciliberto
Rocco Savino
Giacomo Paonessa
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Publication of ITRM950273A0 publication Critical patent/ITRM950273A0/it
Priority to IT95RM000273A priority Critical patent/IT1276555B1/it
Priority to CA002218372A priority patent/CA2218372C/en
Priority to AT96912205T priority patent/ATE233320T1/de
Priority to PCT/IT1996/000084 priority patent/WO1996034104A1/en
Priority to JP53233396A priority patent/JP3373856B2/ja
Priority to US08/945,529 priority patent/US5972902A/en
Priority to DK96912205T priority patent/DK0822986T3/da
Priority to DE69626387T priority patent/DE69626387T2/de
Priority to EP96912205A priority patent/EP0822986B1/en
Priority to PT96912205T priority patent/PT822986E/pt
Priority to ES96912205T priority patent/ES2191096T3/es
Publication of ITRM950273A1 publication Critical patent/ITRM950273A1/it
Application granted granted Critical
Publication of IT1276555B1 publication Critical patent/IT1276555B1/it
Priority to JP2002259481A priority patent/JP2003153691A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IT95RM000273A 1995-04-28 1995-04-28 Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni IT1276555B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT95RM000273A IT1276555B1 (it) 1995-04-28 1995-04-28 Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
DK96912205T DK0822986T3 (da) 1995-04-28 1996-04-26 Antagonister af human interleukin-6, der er fuldstændig ude af stand til at binde GP 130, og deres anvendelse til fremstilling af farmaceutiske forbindelser
EP96912205A EP0822986B1 (en) 1995-04-28 1996-04-26 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
PCT/IT1996/000084 WO1996034104A1 (en) 1995-04-28 1996-04-26 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
JP53233396A JP3373856B2 (ja) 1995-04-28 1996-04-26 Ｇｐ１３０に全く結合することができないヒトインターロイキン−６の拮抗薬、および医薬化合物の製造におけるそれらの使用
US08/945,529 US5972902A (en) 1995-04-28 1996-04-26 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
CA002218372A CA2218372C (en) 1995-04-28 1996-04-26 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
DE69626387T DE69626387T2 (de) 1995-04-28 1996-04-26 Antagonisten von humanem interleukin-6, welche zur bindung mit gp 130 unfähig sind und ihre verwendung in der herstellung von pharmazeutische zusammensetzungen
AT96912205T ATE233320T1 (de) 1995-04-28 1996-04-26 Antagonisten von humanem interleukin-6, welche zur bindung mit gp 130 unfähig sind und ihre verwendung in der herstellung von pharmazeutische zusammensetzungen
PT96912205T PT822986E (pt) 1995-04-28 1996-04-26 Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos
ES96912205T ES2191096T3 (es) 1995-04-28 1996-04-26 Antagonistas de la interleucina-6 humana que es completamente incapaz de unir gp130, y su uso en la preparacion de compuestos farmaceuticos.
JP2002259481A JP2003153691A (ja) 1995-04-28 2002-09-05 Ｇｐ１３０に全く結合することができないヒトインターロイキン−６の拮抗薬をコードする組換えｄｎａ分子、および医薬化合物の製造におけるそれらの使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000273A IT1276555B1 (it) 1995-04-28 1995-04-28 Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni

Publications (3)

Publication Number Publication Date
ITRM950273A0 ITRM950273A0 (it) 1995-04-28
ITRM950273A1 ITRM950273A1 (it) 1996-10-28
IT1276555B1 true IT1276555B1 (it) 1997-11-03

Family

ID=11403338

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95RM000273A IT1276555B1 (it) 1995-04-28 1995-04-28 Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni

Country Status (11)

Country Link
US (1) US5972902A (it)
EP (1) EP0822986B1 (it)
JP (2) JP3373856B2 (it)
AT (1) ATE233320T1 (it)
CA (1) CA2218372C (it)
DE (1) DE69626387T2 (it)
DK (1) DK0822986T3 (it)
ES (1) ES2191096T3 (it)
IT (1) IT1276555B1 (it)
PT (1) PT822986E (it)
WO (1) WO1996034104A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0869176A4 (en) * 1995-11-07 2000-09-20 Kaneka Corp AUTOANTIGENS
WO1997029201A2 (de) * 1996-02-07 1997-08-14 Max-Delbrück-Centrum für Molekulare Medizin Retroviraler vektor für den gentransfer eines il6-antagonisten in humane hämatopoetische stammzellen
CA2284271C (en) 1997-03-21 2012-05-08 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
IT1291932B1 (it) * 1997-06-20 1999-01-21 Angeletti P Ist Richerche Bio Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma
PL356846A1 (en) 2000-03-06 2004-07-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
NZ533223A (en) * 2001-11-14 2007-04-27 Centocor Inc Anti-il-6 antibodies, compositions, methods and uses
US20050100550A1 (en) * 2003-11-10 2005-05-12 Mohit Trikha Anti-angiogenic uses of IL-6 antagonists
ITRM20050103A1 (it) * 2005-03-10 2006-09-11 Rocco Savino Associazione di antagonisti della interleuchina 6 e farmaci antiproliferativi.
PE20061324A1 (es) 2005-04-29 2007-01-15 Centocor Inc Anticuerpos anti-il-6, composiciones, metodos y usos
US8188235B2 (en) 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU687763B2 (en) * 1992-10-20 1998-03-05 Central Laboratory Of The Netherlands Red Cross Blood Transfusion Service Interleukin-6 receptor antagonists
IT1261787B (it) * 1993-06-23 1996-06-03 Angeletti P Ist Richerche Bio Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.

Also Published As

Publication number Publication date
CA2218372A1 (en) 1996-10-31
DE69626387T2 (de) 2003-12-11
JP2003153691A (ja) 2003-05-27
CA2218372C (en) 2001-07-31
US5972902A (en) 1999-10-26
EP0822986B1 (en) 2003-02-26
JPH10506538A (ja) 1998-06-30
DE69626387D1 (de) 2003-04-03
ES2191096T3 (es) 2003-09-01
PT822986E (pt) 2003-07-31
JP3373856B2 (ja) 2003-02-04
ITRM950273A1 (it) 1996-10-28
ITRM950273A0 (it) 1995-04-28
ATE233320T1 (de) 2003-03-15
WO1996034104A1 (en) 1996-10-31
EP0822986A1 (en) 1998-02-11
DK0822986T3 (da) 2003-04-28

Similar Documents

Publication Publication Date Title
FI963101A0 (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
BG102726A (en) Combined therapy for osteoporosis
YU20600A (sh) Nova upotreba antagonista 5-ht3 receptora
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
YU34898A (sh) Antagonisti ccr-3 receptora
ATE450508T1 (de) Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
IT1276555B1 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
GB0111186D0 (en) Novel compounds
AP9801269A0 (en) Prostaglandin agonists.
EP1357909A4 (en) ANTAGONISTS OF IL-8 RECEPTORS
SE9702651D0 (sv) Novel compounds
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
BG108427A (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diaryl pyrimidines as crf1 receptor modulators
AU1092800A (en) N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
MY133845A (en) Il-8 receptor antagonists
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
GB9814892D0 (en) Treatment of celiac disease
DK1240326T3 (da) Udlösende receptor der er involveret i naturlig cytotoxicitet medieret af humane naturlige dræberceller og antistoffer som identificerer denne receptor
AP1548A (en) Il-8 Receptor Antagonists.
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
MXPA04003910A (es) Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar.
SE9702794D0 (sv) New compounds
BG102229A (en) Endothelium receptor antagonists

Legal Events

Date Code Title Description
0001 Granted